These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 4194144)

  • 1. Combined treatment of Parkinson's disease with amantadine and L-dopa.
    Scotti G
    Lancet; 1970 Jun; 1(7661):1394-5. PubMed ID: 4194144
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine versus L-2 dopa and amatadine plus L-dopa.
    Fieschi C; Nardini M; Casacchia M; Tedone ME; Reitano M; Robotti E
    Lancet; 1970 Jul; 2(7664):154-5. PubMed ID: 4194541
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of L-dopa and amantadine in patients with Parkinsonism.
    Cox B; Danta G; Schnieden H; Yuill GM
    J Neurol Neurosurg Psychiatry; 1973 Jun; 36(3):354-61. PubMed ID: 4714097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined treatment of parkinsonism with L-dopa and amantadine.
    Godwin-Austen RB; Frears CC; Bergmann S; Parkes JD; Knill-Jones RP
    Lancet; 1970 Aug; 2(7669):383-5. PubMed ID: 4194690
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of amantadine, placebo, and levodopa in Parkinson's disease.
    Bauer RB; McHenry JT
    Neurology; 1974 Aug; 24(8):715-20. PubMed ID: 4858417
    [No Abstract]   [Full Text] [Related]  

  • 6. Treatment of Parkinson's disease with amantadine and L-Dopa.
    Rinne UK; Sonninen V; Siirtola T
    Eur Neurol; 1972; 7(4):228-40. PubMed ID: 4556618
    [No Abstract]   [Full Text] [Related]  

  • 7. Administration of amandine to patients on optimum L-dopa dosage.
    Fehling C
    Acta Neurol Scand Suppl; 1972; 51():119-20. PubMed ID: 4514335
    [No Abstract]   [Full Text] [Related]  

  • 8. Amantadine and L-dopa.
    Andrews CJ
    Aust N Z J Med; 1972 Aug; 2(3):292-3. PubMed ID: 4508250
    [No Abstract]   [Full Text] [Related]  

  • 9. [Prolonged treatment of Parkinson's disease with amantadine and L-Dopa].
    Fieschi C; Casacchia M; Nardini M; Reitano N
    Minerva Med; 1971 Oct; 62(82):4040-2. PubMed ID: 5125075
    [No Abstract]   [Full Text] [Related]  

  • 10. Amantadine HCL (Symmetrel) and its relation to Levo-Dopa in the treatment of Parkinson's disease.
    Schwab RS; England AC
    Trans Am Neurol Assoc; 1969; 94():85-90. PubMed ID: 4907453
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical evaluation of amantadine therapy for parkinsonism and the side effects--in cases of thalamic surgery and L-dopa therapy.
    Matsumoto K; Omoto T; Beck H
    Folia Psychiatr Neurol Jpn; 1974 Jan; 28(1):1-10. PubMed ID: 4406943
    [No Abstract]   [Full Text] [Related]  

  • 12. [The therapeutic association of L-dopa and amantadine. Preliminary results in a group of patients with Parkinson's disease].
    Gomirato G; Perfetti C
    Riv Neurobiol; 1970; 16(3):247-54. PubMed ID: 5518838
    [No Abstract]   [Full Text] [Related]  

  • 13. Combined L-dopa and amantadine in Parkinsonism.
    Pollock M; Jorgensen PB
    Aust N Z J Med; 1972 Aug; 2(3):252-5. PubMed ID: 4564049
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of Parkinson's disease with amantadine and levodopa].
    Fieschi C; Nardini M; Casacchia M; Reitano M; Tedone ME; Ferrari P; Robotti E
    Sist Nerv; 1970; 22(2):126-43. PubMed ID: 5504552
    [No Abstract]   [Full Text] [Related]  

  • 15. [Results of two new drugs in Parkinson's disease: L-dopa and amantadine].
    Sigwald J; Raymondeaud C; Piot C
    Rev Neurol (Paris); 1970 Feb; 122(2):145-8. PubMed ID: 4931718
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].
    Fasano VA; Urciuoli R; Broggi G
    Minerva Med; 1970 Jul; 61(53):2895-903. PubMed ID: 5428170
    [No Abstract]   [Full Text] [Related]  

  • 17. Parkinson's disease and amantadine hydrochloride.
    JAMA; 1969 May; 208(7):1180-1. PubMed ID: 5818720
    [No Abstract]   [Full Text] [Related]  

  • 18. Amantadine in the treatment of Parkinson's disease.
    Schwab RS; England AC; Poskanzer DC; Young RR
    JAMA; 1969 May; 208(7):1168-70. PubMed ID: 5818715
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of adding amantadine to optimum L-dopa dosage in Parkinson's syndrome.
    Fehling C
    Acta Neurol Scand; 1973; 49(2):245-51. PubMed ID: 4577929
    [No Abstract]   [Full Text] [Related]  

  • 20. L-dopa and amantadine hydrochloride in Parkinson's disease.
    Parkes JD; Zilkha KJ; Knill-Jones RP; Clements PJ; Baxter R
    Int Z Klin Pharmakol Ther Toxikol; 1971 Apr; 4(3):356-60. PubMed ID: 4931417
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.